NIKOLA CORP (NKLA)

US6541101050 - Common Stock

0.5349  -0.01 (-2.67%)

After market: 0.5423 +0.01 (+1.38%)

Fundamental Rating

2

NKLA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. Both the profitability and financial health of NKLA have multiple concerns. While showing a medium growth rate, NKLA is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year NKLA has reported negative net income.
NKLA had a negative operating cash flow in the past year.
In the past 5 years NKLA reported 4 times negative net income.
NKLA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -82.01%, NKLA is doing worse than 92.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of -161.17%, NKLA is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
ROA -82.01%
ROE -161.17%
ROIC N/A
ROA(3y)-69.65%
ROA(5y)-48.86%
ROE(3y)-127.62%
ROE(5y)-84.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NKLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

NKLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NKLA has been increased compared to 1 year ago.
Compared to 5 years ago, NKLA has more shares outstanding
NKLA has a better debt/assets ratio than last year.

2.2 Solvency

NKLA has an Altman-Z score of -4.74. This is a bad value and indicates that NKLA is not financially healthy and even has some risk of bankruptcy.
NKLA has a Altman-Z score of -4.74. This is amonst the worse of the industry: NKLA underperforms 88.46% of its industry peers.
NKLA has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
NKLA has a Debt to Equity ratio (0.46) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -4.74
ROIC/WACCN/A
WACC8.1%

2.3 Liquidity

NKLA has a Current Ratio of 1.73. This is a normal value and indicates that NKLA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NKLA (1.73) is worse than 64.62% of its industry peers.
A Quick Ratio of 1.50 indicates that NKLA should not have too much problems paying its short term obligations.
NKLA has a better Quick ratio (1.50) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.5

6

3. Growth

3.1 Past

NKLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.66%, which is quite impressive.
The Revenue for NKLA has decreased by -45.61% in the past year. This is quite bad
NKLA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 610.32% yearly.
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q65.38%
Revenue 1Y (TTM)-45.61%
Revenue growth 3Y610.32%
Revenue growth 5YN/A
Revenue growth Q2Q-32.56%

3.2 Future

Based on estimates for the next years, NKLA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.54% on average per year.
The Revenue is expected to grow by 158.27% on average over the next years. This is a very strong growth
EPS Next Y52.67%
EPS Next 2Y27.95%
EPS Next 3Y22.54%
EPS Next 5Y15.54%
Revenue Next Year344.38%
Revenue Next 2Y256.48%
Revenue Next 3Y228.78%
Revenue Next 5Y158.27%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NKLA. In the last year negative earnings were reported.
Also next year NKLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NKLA's earnings are expected to grow with 22.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.95%
EPS Next 3Y22.54%

0

5. Dividend

5.1 Amount

NKLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NIKOLA CORP

NASDAQ:NKLA (5/17/2024, 7:16:11 PM)

After market: 0.5423 +0.01 (+1.38%)

0.5349

-0.01 (-2.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap725.42M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.01%
ROE -161.17%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.73
Quick Ratio 1.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y52.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-45.61%
Revenue growth 3Y610.32%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y